First, on the links between Aβ oligomers and tau and Ca2+ dysregulation, and second, on the effect of several mutations producing familiar Alzheimer’s disease on Ca2+ signaling. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.